Company · Biotechnology Research
Medicines Development For Global Health
Medicines Development for Global Health (MDGH) develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a not-for-profit pharmaceutical company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received US FDA approval of moxidectin, the first new treatment for River Blindness in more than 30 years. Next we're turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Read more at medicinesdevelopment.com Games to be changed. Much work to do. Sign up for our quarterly newsletter here: https://bit.ly/3mwzi0N
Team composition
Roles at Medicines Development For Global Health
11 to 50 staff
- 3senior development manager
- 2senior clinical project manager
- 1associate director - clinical
- 1associate director and project lead
- 1cosultant, epidemiologist
- 1development manager
- 1director
- 1director, clinical operations
- 1drug development cmc
- 1executive assistant
- +8more roles
On record
Showing 9 of 21
Vidya U•••
Senior Clinical Project Manager
Amanda H•••
Vice President, Head of Development
Barbara R•••
Senior Medicines Access Manager
Danielle S•••
Senior Director & Global Head of Regulatory Affairs
Emily M•••
Head of Philanthropy
Jane F•••
Director, Clinical Operations
Lydia I•••
Associate Director and Project Lead
Melinda L•••
Principal Development Manager, Clinical
Molly K•••
Senior Development Manager
Reveal on Kipplo
Get the full team — names, verified emails, phone numbers — in the Kipplo app.
Unlock teamFiled under Biotechnology Research in Australia.